Voluntary Euthanasia Motion for Papers Sample Clauses

Voluntary Euthanasia Motion for Papers. (1950) The question of legalisation of voluntary euthanasia came again to be debated in the Lords in 1950 in a motion for papers.19 As with the debate on the Voluntary Euthanasia (Legalisation) Bill (1936), the objections to the Bill were principally material 12 ibid 492-3 (Lord Horder). 13 ibid 487 (Archbishop of Canterbury). 14 ibid 491 (Lord Horder). 15 ibid. 16 ibid 479-80 (Viscount Xxxxxxxx). 17 ibid 484-5 (Xxxx Xxxxxx). 18 ibid 488. 19 HL Deb, ‘Voluntary Euthanasia’ 1950, 28 Nov, vol 169 cols 552-598 http://xxxxxxx.xxxxxxxxxxxxxxx.xxx/lords/1950/nov/28/voluntary-euthanasia accessed 2015/12/12. rather than spiritual, with religious argument again largely absent but for one speaker.20 There appears to have been a detectable shift in emphasis, however, toward increasing reliance on the slippery slope argument,21 which was often joined with the view that all human life is precious (sanctity of life argument): [O]ne of the great characteristics of our civilisation, contrasted with the materialistic civilisation of Communism, is the value we attach to every human life. Imperceptibly and gradually this value in human life will be reduced if by law it is possible year by year to kill a large number of people.22 The abuse argument also remained a central concern,23 and it is interesting to note its development from an argument principally about pressure as a product of third party agency (passive abuse argument), into one concerned with voluntariness and the idea that individuals would experience a weight of expectation to request euthanasia (passive abuse argument): [R]eally conscientious old people, who even now get extremely worried because they feel that they are a burden on those upon whom they are dependent. I can imagine the way in which their consciences would in future be torn, wondering whether they ought to apply for this euthanasia so as to relieve those who are caring for them of the burden.24 Another noticeable difference between the 1936 and 1950 debates was the move by medical peers from the position where euthanasia might potentially fall within the province of the medical profession to one in which physicians had no role in the intentional killing of others per their request or otherwise; the professional autonomy argument was thus recast so as to exclude assisted death as a means to further the goals of medicine.25 This shift was perhaps attributable to disapproval of Nazi medical practice characterised as ‘euthanasia’.26 20 ibid 570 et seq...
AutoNDA by SimpleDocs

Related to Voluntary Euthanasia Motion for Papers

  • Termination Procedures and Compensation During Dispute 7.1. After a Change in Control and during the term of this Agreement, any purported termination of the Executive's employment (other than by reason of death) shall be communicated by written Notice of Termination from one party hereto to the other party hereto in accordance with Section 10 hereof. For purposes of this Agreement, a "

  • Termination for Patent Challenge If, during the Term, AbbVie or any of its Affiliates or Sublicensees of Morphic Patents under this Agreement: (a) [***]; or (b) [***] (each of (a) and (b), a “Patent Challenge”), then except as otherwise set forth in this Section 12.2.5, Morphic shall have the right to terminate this Agreement upon at least [***] prior written notice to AbbVie; provided, that Morphic shall not have the right to terminate this Agreement if within [***] after receipt of such written notice from Morphic, (i) AbbVie or its Affiliate, as applicable, rescinds any and all of such Patent Challenge (or in the case of ex-parte proceedings, multi-party proceedings, or other Patent Challenges that AbbVie or such Affiliate does not have the power to unilaterally withdraw or cause to be withdrawn, AbbVie and its Affiliate, as applicable, knowingly ceases providing any support or assistance to any Person with respect to such Patent Challenge and, to the extent AbbVie or any of its Affiliates is a party to such Patent Challenge, it withdraws from such Patent Challenge) and provided, that neither AbbVie nor any AbbVie Affiliate thereafter continues such Patent Challenge or, knowingly, the provision of any direction, support or assistance to any Person in respect of the same or (ii) if such Patent Challenge is brought by a Sublicensee, AbbVie or its Affiliate terminates such Sublicensee’s sublicense or other right or authorization to the relevant Patent and ceases providing any direction, support or assistance to such Sublicensee related to such Patent Challenge, unless such termination is prohibited under Applicable Law. Notwithstanding the foregoing, Morphic shall not have the right to terminate this Agreement pursuant to this Section 12.2.5 if AbbVie or its Affiliate or Sublicensee takes any action described in clause (a) or (b) of the foregoing definition of Patent Challenge (x) in a proceeding involving a Morphic Patent where AbbVie, an Affiliate or Sublicensee has been compelled to participate in the proceeding by a court, patent office, or Third Party (other than any Sublicensee) or (y) that is necessary or reasonably required to assert a cross-claim or a counterclaim or to respond to a court request or order or administrative law request or order, including asserting any defense or counterclaim in, or otherwise responding to, an action for infringement of intellectual property asserted, filed, or threatened to be filed, against AbbVie or its Affiliate or Sublicensee by Morphic or any of its Affiliates or its (sub)licensees. In addition, Morphic shall not have the right to terminate this Agreement pursuant to this Section 12.2.5 if any Affiliate that first becomes an Affiliate of AbbVie after the Effective Date was undertaking activities in connection with a Patent Challenge prior to such Affiliate first becoming an Affiliate of AbbVie if AbbVie causes such Patent Challenge to be withdrawn (or in the case of ex-parte proceedings, multi-party proceedings, or other Patent Challenges that such Affiliate does not have the power to unilaterally withdraw or cause to be withdrawn, such Affiliate knowingly ceases providing any direction, support or assistance to any Person with respect to such Patent Challenge and, to the extent such Affiliate is CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED. a party to such Patent Challenge, it withdraws from such Patent Challenge) within the later to occur of (A) [***] of the date such Affiliate first becomes an Affiliate of AbbVie and (B) [***] following the date Morphic provides AbbVie notice regarding such Patent Challenge and in all cases, provided, that neither AbbVie nor any AbbVie Affiliate thereafter continues such Patent Challenge or, knowingly, the provision of any direction, support or assistance to any Person in respect of the same.

  • Late Application for Parental Leave When an application for parental leave under sub-article (A) above is not made in accordance with sub-article (c), the employee is nonetheless entitled to, and upon application to the Co-operative shall be granted, parental leave under this Article for the portion of the leave period that remains at the time the application is made.

  • SALARY DETERMINATION FOR EMPLOYEES IN ADULT EDUCATION PCA Article B.3 does not apply in School District No. 34 (Abbotsford).

  • CREDIT FOR PREVIOUS EXPERIENCE All employees shall be classified according to previous comparable supermarket experience. Previous comparable experience shall be granted on the following basis:

  • Reporting Total Compensation of Recipient Executives 1. Applicability and what to report. You must report total compensation for each of your five most highly compensated executives for the preceding completed fiscal year, if—

  • Motion for Preliminary Approval The Parties agree to jointly prepare and file a motion for preliminary approval (“Motion for Preliminary Approval”) that complies with the Court’s current checklist for Preliminary Approvals.

  • Application for Employment Employee understands and agrees that, as a condition of this Agreement, Employee shall not be entitled to any employment with the Company, and Employee hereby waives any right, or alleged right, of employment or re-employment with the Company. Employee further agrees not to apply for employment with the Company and not otherwise pursue an independent contractor or vendor relationship with the Company.

  • Application for Benefits Requests for short-term leaves shall be in writing, upon the appropriate form prescribed and provided by the District, and shall be filed with the unit member's supervisor and the appropriate manager five (5) days in advance of the intended leave (except in emergency situations), unless otherwise stated by the provisions of the specific leave.

  • Application for Payment The form acceptable to Owner that is to be used by the Contractor during the course of the Work in requesting payment from the Owner and that is to be accompanied by such supporting documentation as is required by the Contract Documents.

Time is Money Join Law Insider Premium to draft better contracts faster.